17 Matching Annotations
  1. Sep 2024
    1. Tests performed: Haemostatic tests ristocetin-induced platelet aggregation plasma VWF antigen VWF risocetin cofactor VWF FVIII-binding capacity VWF multimers and FVIII activity DDAVP test Concentration timecourses

      sequencing from genomic DNA performed and reported in 2011

      cDNA analysis

      Real-time-PCR analysis

      long PCR

      Ellman assay (quantifying sulfhydryls)

      Dynamic light scattering measurements

      circular dichroism

      ADAMTS13 proteolysis assay

      ADAMTS13-VWF binding assay

  2. Aug 2024
  3. Jul 2023
    1. preoperative stereotactic RT (5 × 5 Gy), surgery, and postoperative normofractionated RT (25 × 2 Gy)

      RT hipofx sarcoma preOP - SBRT preOP 25Gy/5fx - Cirugía - RT convencional PO (50Gy/25fx)

    1. GTV prescription was commonly 52.5 Gyin 15 fractions

      Sarcoma metastásico o irresecable RT hipofraccionada: GTV 52.5 Gy en 15 fx --> CTV 45 Gy en 15 fx GTV 45Gy en 15 fx --> CTV 37.5 Gy en 15 fx

    2. 5 Gy in 15 fractions (59% ≥45 Gy)

      Sarcoma metastásico o irresecable RT hipofraccionada: 45Gy en 15 fx

  4. Jun 2023
    1. Adjuvantradiotherapy ranging in dosage from 54 Gy to 62 Gy was administered to patients whoexhibited deep-seated, high-grade tumors that were larger than 5 cm

      Dosis y beneficio RT adyuvante TMVNP: * Dosis: 54-62 Gy en tumor profundo, alto grado, >5cm * Beneficio en SLE y SG a 5 años A 5 años: * SLE: 42% con RT vs 0% sin RT * SG: 65% con RT vs 38% sin RT

    1. radiotherapy is most useful in patients with large (e.g., >5 cm), high-grade tumors, and/or those with positive margins at resection

      Indicaciones RT adyuvante en TMVNP: * Tamaño >5cm * Alto grado * Margen positivo

    2. used 45 Gy (25 fractions of 1.8 Gy) neoadjuvant radiotherapy to the primary site, followed by resection and adjuvant radiotherapy with the dose determined by the success of resection–10.8 Gy (6 fractions of 1.8 Gy) for microscopic residual disease R1 (cumulative dose 55. 8 Gy) or 19.8 Gy (11 fractions of 1.8 Gy) for gross residual disease/no resection (cumulative dose 64.8 Gy)

      RT neo: 45 Gy + RT PO: 10.8Gy/6fx en R1, 19.8Gy/11fx en R2

  5. Dec 2022
    1. The style is one that is now widely recognized as a tool of sowing doubt: the author just asked ‘reasonable’ questions, without making any evidence-based conclusions.Who is the audience of this story and who could potentially be targeted by such content? As Bratich argued, 9/11 represents a prototypical case of ‘national dissensus’ among American individuals, and an apparently legitimate case for raising concerns about the transparency of the US authorities13. It is indicative that whoever designed the launch of RT US knew how polarizing it would be to ask questions about the most painful part of the recent past.
    2. To begin with, the US output of RT tapped into the rich American culture of conspiracy theories by running a story entitled ‘911 questions to the US government about 9/11’
    3. Instead, to counter US hegemonic narratives, the Kremlin took to systematically presenting alternative narratives and dissenting voices. Russia’s public diplomacy tool — the international television channel Russia Today — was rebranded as RT in 2009, probably to hide its clear links to the Russian government11. After an aggressive campaign to expand in English-, Spanish-, German- and French-speaking countries throughout the 2010s, the channel became the most visible source of Russia’s disinformation campaigns abroad. Analysis of its broadcasts shows the adoption of KGB approaches, as well as the use of novel tools provided by the global online environment
  6. Aug 2022
  7. Sep 2021
  8. Apr 2021
    1. bacteria10

      Only intracellular pathogen bacteria infecting mammalian cells has been reported in 10. Would be interesting to see if this works for a culture of E. coli

  9. Mar 2021
    1. The TURBO DNA-free™ Kit contains reagents for the efficient, complete digestion of DNA along with the removal of the enzyme and divalent cations post-digestion.
  10. Oct 2020